3
Total investments
0
Early stage
0
Mid stage
0
Late stage
15y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
C
Board Member
May 2014
Chrono Therapeutics is focused on improving clinical outcomes for patients battling addictions and living with neurological disorders via our proprietary Digital Patch platform, pioneering a new era of transdermal drug delivery designed to meet each patient's individual needs. By integrating timed drug delivery with personalized, mobile-phone-based digital support and unique data analytics to maximize compliance, we help patients manage hard to treat conditions and optimize clinical outcomes.
We have multiple programs in active development that address significant market opportunities with unmet (or poorly) met needs. Each of our programs leverages medications that readily cross the skin. In addition to the programs currently in development for smoking cessation, Parkinson's Disease dyskinesia and prescription opioid dependence, our discovery pipeline is robust, with a number of CNS indications under evaluation that would benefit from a therapeutic combined with behavioral and compliance support.
Experience · 8 entries
All (8)
Investments (3)
Founder (1)
Board (3)
2014
A
Arivale
Board Member
Dec 2014
C
Board Member
May 2014
Chrono Therapeutics is focused on improving clinical outcomes for patients battling addictions and living with neurological disorders via our proprietary Digital Patch platform, pioneering a new era of transdermal drug delivery designed to meet each patient's individual needs. By integrating timed drug delivery with personalized, mobile-phone-based digital support and unique data analytics to maximize compliance, we help patients manage hard to treat conditions and optimize clinical outcomes.
We have multiple programs in active development that address significant market opportunities with unmet (or poorly) met needs. Each of our programs leverages medications that readily cross the skin. In addition to the programs currently in development for smoking cessation, Parkinson's Disease dyskinesia and prescription opioid dependence, our discovery pipeline is robust, with a number of CNS indications under evaluation that would benefit from a therapeutic combined with behavioral and compliance support.
2013
CEO-in-Residence
Apr 2013
Exceptional entrepreneurs. Remarkable bonds. Extraordinary companies.
Since 1996, Polaris has been guided by the fundamental beliefs that people come first and true partnerships make all the difference.
Rooted in mutual respect and a shared passion for innovation, our relationships with outstanding visionaries principally in technology and healthcare have helped to change the world for the better.
Co-founder and CEO
Apr 2013
Mazlo Marketing provides branding support to organizations that are truly committed to sustainable impact. We deliver profitable regional and global opportunities that most organizations wouldn’t be able to find on their own.
The sustainable actions our clients are engaged in positively influence the environment, benefit charities, or simply make the world a better place. However, we believe it's not enough to engage in sustainable business practices solely to appear better than your competitors, or to feel better about yourself as a person or as an organization. A real commitment to corporate altruism must center around the need to actually be better.
CEO-in-Residence
Apr 2013
Exceptional entrepreneurs. Remarkable bonds. Extraordinary companies.
Since 1996, Polaris has been guided by the fundamental beliefs that people come first and true partnerships make all the difference.
Rooted in mutual respect and a shared passion for innovation, our relationships with outstanding visionaries principally in technology and healthcare have helped to change the world for the better.
Show all 8 entries ↓
Investment activity
2011–2014 · 3 investments
Recent (last 2 years)Earlier
